Dr. Sulaiman Al-habib Medical Services Group Co. · TADAWUL:4013
Dr. Sulaiman Al-habib Medical Services — Q2 2023 Earnings Presentation
37 slides from Dr. Sulaiman Al-habib Medical Services's earnings presentation, Aug 23, 2023
Slide 1: Q2 2023 Investor Presentation
Q2 2023 Investor Presentation As of 23 August 2023
Slide 2: Disclaimer
DISCLAIMER Disclaimer and important information in relation to this presentation This presentation is for general use only and is not necessarily comprehensive as it has not been independently verified, nor is it considered or constitutes part of any invitation or inducement to engage in any investm
Slide 3: Presenting Team
PRESENTING TEAM Faisal Al Nassar Ziyad Al Dahami Acting CEO Head of Treasury and Investor Relations Q2 2023 Investor Presentation 3 August 2023
Slide 4: Agenda
AGENDA Financial Performance Operational Highlights Appendix #1 Summarized Financials Appendix #2 About HMG
Slide 5: Financial Performance
us! ULoatin.s DR SULAIMAN AL HABIB medical group auiJlacgo3oll Financial Performance
Slide 6: Key Financial Highlights: Q2 2023
KEY FINANCIAL HIGHLIGHTS : Q2 2023 Revenue by segment SAR million +12.82% Gross profit 15.50% Gross profit Margin Q2 2023 774.83 Q2 2023 34.10% Q2 2022 Q2 2023 Q2 2022 670.87 Q2 2022 33.31% SAR (Millions) 73.19 59.85 3.64% 2.63% 406.66 483.71 20.19% 21.29% EBITDA 16.88% EBITDA margin 2,014.01 2,272.
Slide 7: Key Financial Highlights: H1 2023
KEY FINANCIAL HIGHLIGHTS : H1 2023 Revenue by segment SAR million +14.34% Gross profit 17.23% Gross profit Margin H1 2023 1,558.47 H1 2023 34.03% H1 2022 H1 2023 H1 2022 1,329.44 H1 2022 33.20% SAR (Millions) 140.96 122.89 3.52% 2.68% 823.60 974.44 20.56% 21.28% EBITDA 18.26% EBITDA margin 4,004.87
Slide 8: Balance Sheet Highlight
BALANCE SHEET HIGHLIGHT H1 2022 H1 2023 Total assets Total assets SAR 11.85 billion SAR 13.99 billion ROE ROA H1 2023 33.12% H1 2023 15.11% Cash, time 17.43% Current deposit & bank 23.50% 18.90% 19.93% H1 2022 29.51% H1 2022 14.42% liabilities balances Accounts 7.02% receivable 7.05% 4.11% Non- ROCE
Slide 9: Low Leverage Levels
LOW LEVERAGE LEVELS Total liabilities and equity SAR million 120.00% Total Liabilities/Total Assets Total Liabilities/Equity H1 2023 0.54x H1 2023 1.17x 100.00% H1 2022 0.51x H1 2022 1.04x 80.00% 48.93% 46.09% 5,799.00 6,446.97 Debt / Equity Net Debt / EBITDA 60.00% H1 2023 0.66x H1 2023 0.74x H1 20
Slide 10: Total Cash Dividends for Shareholders
TOTAL CASH DIVIDENDS FOR SHAREHOLDERS Declared dividends Declared Cash dividends / Q2 2023 Total distributed dividends SAR 350.00 million 0 50 100 150 200 250 300 350 400 Q2 2023 SAR 1.00 per share SR 350.0mn 71.9% Payout Q1 2023 SR 350.0mn 71.5% Payout % of capital 10% (equivalent to SAR 1.00 per s
Slide 11: Operational Highlights
u4i14I5!yuLgitiu.s DR SULAIMAN AL HABIB medical group auhiiac9.o2.0/) Operational Highlights
Slide 12: Q2 2023 Highlights
Q2 2023 HIGHLIGHTS Key Highlights HMG Mobile Application Interaction Signed conditional investment agreement with the Royal 130 mn+ Commission for Jubail and Yanbu to allocate land in Jubail Industrial City to construct and operate a hospital. Booked Appointments 940 k+ appointments Signed cooperati
Slide 13: Q2 2023 Highlights: Recognitions & Accreditations
Q2 2023 HIGHLIGHTS Recognitions & Accreditations HMG continues to receive recognitions HMG received Excellence Award from Saudi Arabian Cardiac Interventional Society (SACIS). HMG was and accreditations from organizations awarded the Excellence in Medical Services prize for the remarkable successes
Slide 14: Q2 2023 Highlights: Medical Excellence
Q2 2023 HIGHLIGHTS MEDICAL EXCELLENCE Creating the medical practitioners of the future and promoting health and well-being Postgraduate Program Research Center CPR 24 Residency & Fellowship program 5 Journals 200+ Courses accredited by SCFHS 12 Research papers published 190 participant 35
Slide 15: Projects Update
PROJECTS UPDATE Solidifying our market leadership through a robust expansion plans and progressing our projects Maternity and Pediatric Hospital North Riyadh Hospital South-West Jeddah Hospital (New Takhassusi Expansion) 100% 2023 50% 2023 100% 2024 Ownership Expected Ownership Expected Ownership Ex
Slide 16: Projects Update
PROJECTS UPDATE Solidifying our market leadership through a robust expansion plans and progressing our projects North Jeddah Hospital Sehat Al Kharj Hospital Al Hamra Hospital 100% 2024 100% 2024 100% 2025 Ownership Expected Ownership Expected Ownership Expected Land Design MoH Excavation Constructi
Slide 17: Projects Update
PROJECTS UPDATE Solidifying our market leadership through a robust expansion plans and progressing our projects Al Madinah Al Munawwarah Hospital Tabuk Hospital Medical Centers Expansion Land 50 Land 50 100% 2024 Leased agreement Years Leased agreement Years Ownership Expected Riyadh Buraidah Dammam
Slide 18: Our People
OUR PEOPLE Continued to attract and retain top talent in the Kingdom PEOPLE PHYSICIANS 14,000+ 57% female 36% 3,200+ +90% 15+ average years Employees 43% male Saudization Physicians Retention Rate Experience Staff ratio 75+ 120+ Physician Qualifications Nationalities Recruiting offices across the gl
Slide 19: ESG & Sustainability
ESG & SUSTAINABILITY The Group’s ESG structures and targets aim to maximize the benefits we deliver in terms of patient health, the broader contexts of social and human development, and responsible environmental stewardship ESG Roadmap HMG is currently undertaking a four-phase exercise to start inte
Slide 20: Appendix #1: Summarized Financials
Appendix #1 Summarized Financials
Slide 21: Summary: Balance Sheet
SUMMARY: BALANCE SHEET As of 30 June 2023 SAR million H1 2023 H1 2022 Current Assets 4,304.03 4,360.13 Investment in Associates 185.93 178.08 Investments in equity instruments – Sukuk 300.00 150.00 Property and Equipment 9,198.72 7,164.18 Total Assets 13,988.68 11,852.39 Current Liabilities 2,788.51
Slide 22: Summary: Income Statement
SUMMARY: INCOME STATEMENT As of 30 June 2023 SAR million H1 2023 H1 2022 Change % Revenue 4,579.14 4,004.87 14.34% Cost of revenue (3,020.67) (2,675.43) 12.90% Gross profit 1,558.47 1,329.44 17.23% Selling and marketing expenses (184.84) (162.30) 13.89% General and administrative expenses (364.25) (
Slide 23: Summary: Cash Flow Statement
SUMMARY: CASH FLOW STATEMENT As of 30 June 2023 SAR million H1 2023 H1 2022 Net cash from operating activities 1,119.70 1,174.06 Net cash used in investing activities (1,392.19) (911.04) Net cash used in financing activities (35.65) (121.05) Cash and cash equivalents at the beginning of the year 2,7
Slide 24: Appendix #2: About HMG
us! Uloatin.s DR SULAIMAN AL HABIB medical group auhJlacgololl Appendix #2
Slide 25: Diverse Board of Directors
DIVERSE BOARD OF DIRECTORS Our success is driven by our people 2 NON-EXECUTIVES 2 EXECUTIVES 4 INDEPENDENTS Mr. Faisal Al Nassar Dr. Sulaiman Al Habib Mr. Mazen Al Rumaih Board Member, Chairman Vice Chairman Acting CEO & CFO Mr. Obaid Al Rasheed Mr. Hesham Al Habib Board Member Eng. Saleh Al Habib B
Slide 26: HMG's Committees
HMG’s COMMITTEES Our success is driven by our people NOMINATION & PATIENT SAFETY & AUDIT RENUMERATION EXECUTIVE QUALITY OF CARE COMMITTEE COMMITTEE COMMITTEE COMMITTEE Dr. Abdulrahman Al Turaigi Mr. Obaid Al Rasheed Mr. Mazen Al Rumaih Prof. Mahmoud Al Ahwal Chairman Chairman Chairman Chairman Mr. R
Slide 27: Experienced Senior Management
EXPERIENCED SENIOR MANAGEMENT Highly experienced, high caliber management Mr. Faisal Al Nassar Acting CEO & CFO CORE FUNCTIONS CORPORATE FUNCTIONS INDEPENDENT FUNCTIONS Dr. Abdulwahab Mr. Badr Al Dr. Riyad Al Atiqi Mr. Hesham Al Habib Eng. Abdullah Al Abdulwahab Chief Business Rowaili General Direct
Slide 28: A Fully Integrated Healthcare Services Provider
A FULLY INTEGRATED HEALTHCARE SERVICES PROVIDER Dr. Sulaiman Al Habib Medical Services Group Company (HMG) is a diversified healthcare 22 60+ leader in the Middle East, recognized for Medical Facilities Sub-specialties comprehensive healthcare services, forward- thinking innovation and the superior
Slide 29: Our Strategy
OUR STRATEGY Our well-defined growth strategy enhanced by our core values Our Value Our Pillar Our Priorities Strengthening our core Drivers: Human capital, cutting-edge technology and Provide integrated Maintain position as Integrity Care for Patients operational efficiency healthcare services lead
Slide 30: Key Message
KEY MESSAGE Strategic pillars underpin our drive to deliver best-in-class healthcare services Best-in-class Catalysts for value creation Efficiency drivers • Regional integrated healthcare • Technology: Pioneer in healthcare • Efficient cash conversion cycle: provider with 25+ year track record tech
Slide 31: Business Model
BUSINESS MODEL Through our vertically integrated business model, we are committed to create sustainable value for our stakeholders OUR KEY STRENGTHS WHAT WE DO HOW WE MAXIMISE VALUE Cutting-edge Technology 01 Patient-centric approach Facilities and services Leading Brand in Prime Locations 02 Contin
Slide 32: Business Structure
BUSINESS STRUCTURE A fully integrated healthcare services provider HOSPITALS & PHARMACIES HMG SOLUTIONS HEALTHCARE FACILITIES Cloud Providing leading-edge technological 22 Medical facilities Outpatient pharmacies as part of Solutions solutions to boost healthcare quality and the hospitals patient ex
Slide 33: Where We Operate
WHERE WE OPERATE With total built-up area of 689,000+ m2, HMG owns most of its hospital properties Tabuk KINGDOM OF Hospital SAUDI ARABIA Kingdom of Hospital under construction Bahrain Dammam Medical Center Khobar Qassim Dubai Madinah Riyadh Medical Center under construction UAE Kharj Operated contr
Slide 34: Our Story
OUR STORY Olaya Medical Dubai Medical Center Maternity Hospital Qassim Hospital Complex 2007 2008 2009 1995 MD Lab Takhassusi Hospital University Medical Home Bone, Joint & Rayan Hospital 2013 2012 Center in Bahrain Healthcare Spinal Hospital 2010 2011 2011 2010 Cloud Dubai Hospital Suwaidi Hospital
Slide 35: Medical Excellence
MEDICAL EXCELLENCE Medical Operation Strategic Pillars Performance & Efficiency HMG significantly reduced the admission waiting time for our patients and ensured their timely discharge from our hospitals. Patient Safety HMG artificial heart and lung program is one of many sophisticated services that
Slide 36: Pioneer in Healthcare Technology
PIONEER IN HEALTHCARE TECHNOLOGY Better medical outcomes, exceptional patient experience, and advanced operational practices E-medicine HIS (VIDA) Developing cutting edge technology Tele-Cardiology (Nabad 24 program) Pioneer in healthcare technology, award-winning 10 Digital hospitals • Designed to
Slide 37: Thank you
Thank you Dr. Sulaiman Al Habib Medical Services Group Tel: +966 11 525 9999 Ext# 4919 Mobile: +966 50 338 2785 Email: investor.relations@drsulaimanalhabib.com Website: www.hmg.com
Dr. Sulaiman Al Habib Medical Services Group — Q2 2023 Earnings Presentation on 6ix